Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Xavier Pivot

1-50 of 192 results

View this query on the Wikidata Query Service
International network of cancer genome projects

scientific article
Landscape of somatic mutations in 560 breast cancer whole-genome sequences

scientific article
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.

scientific article published on 03 June 2017
Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer.

scientific article
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.

scientific article published on 11 June 2013
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine

scientific article published on 02 July 2007
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.

scientific article published on 19 February 2013
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3

scientific article published on 03 June 2018
Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study.

scientific article published on 7 November 2016
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

scientific article published on 16 March 2010
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.

scientific article published on 5 September 2010
Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01).

scientific article published in September 2003
Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience

scientific article
Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancer.

scientific article published on 28 December 2009
Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up

scientific article published on 01 July 2003
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study

scientific article published on 28 July 2014
Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results from AVADO

scientific article published on 15 July 2011
A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers

scientific article published on 13 July 2016
Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer.

scientific article published in September 2004
Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

scientific article
The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.

scientific article published on 07 April 2008
Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy response.

scientific article
A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

scientific article published on April 1999
Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysis.

scientific article published in January 1998
Prospective analysis of the impact of VEGF‐A gene polymorphisms on the pharmacodynamics of bevacizumab‐based therapy in metastatic breast cancer patients

scientific article published on June 1, 2011
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study.

scientific article published on 17 November 2014
Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.

scientific article
Impact of chemotherapy beyond the first line in patients with metastatic breast cancer

scientific article published on 23 March 2007
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study

scientific article published on 19 February 2011
Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.

scientific article
Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer

scientific article published on 01 March 2005
A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage.

scientific article published in January 2000
Endpoints in cancer clinical trials

scientific article published on 14 January 2014
Efficacy and safety of ixabepilone, a novel epothilone analogue.

scientific article published on April 2007
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

scientific article published on 06 June 2019
A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2-positive early breast cancer

scientific article published on 25 January 2016
Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes

scientific article published on 01 March 2007
HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant-adjuvant trastuzumab after 2 years of treatment-free follow-up.

scientific article
Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer.

scientific article published on 24 March 2010
Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study.

scientific article published on 7 July 2015
Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.

scientific article published on 01 September 1998
The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy

scientific article published on 01 November 2001
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.

scientific article
A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results.

scientific article published on 12 February 2018
Pooled analyses of eribulin in metastatic breast cancer patients with at least one prior chemotherapy.

scientific article published on 13 May 2016
A retrospective study of first indicators of breast cancer recurrence

scientific article published on 01 April 2000
Maintenance hormonal treatment improves progression free survival after a first line chemotherapy in patients with metastatic breast cancer

scientific article published on 5 May 2008
Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study

scientific article published on 25 June 2015
Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive

scientific article published on 26 January 2018
Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

scientific article published in October 2003

Paulina is supported by:

About Paulina

Help